Coronary flow reserve in patients with resistant hypertension

Sebastian Völz1, Sara Svedlund2, Bert Andersson3

  • 1Department of Cardiology, Sahlgrenska University Hospital, 4 Bruna Straket, 41345, Gothenburg, Sweden. sebastian.volz@vgregion.se.

Insights

Resistant hypertension is linked to poorer cardiac microvascular function, indicated by reduced coronary flow reserve (CFR). This finding highlights a potential mechanism for increased cardiovascular risk in these patients.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Cardiovascular Physiology

Background:

  • Resistant hypertension elevates cardiovascular event risk.
  • Coronary flow reserve (CFR) impairment predicts cardiac mortality in hypertension.
  • Data on CFR in treatment-resistant hypertension is lacking.

Purpose of the Study:

  • To evaluate coronary flow reserve (CFR) in patients with resistant hypertension.
  • To compare CFR between resistant hypertension, controlled hypertension, and healthy individuals.

Main Methods:

  • Transthoracic color Doppler echocardiography during adenosine infusion.
  • Measurement of mean flow velocity in the left anterior descending coronary artery.
  • Pair-matching of hypertensive patients (resistant vs. controlled) and age/sex-matched healthy controls.

Main Results:

  • Resistant hypertension patients had significantly lower CFR (2.7 ± 0.6) than non-resistant hypertensive patients (3.1 ± 0.8; p=0.03).
  • Systolic office blood pressure was higher in resistant hypertension (169 ± 20 vs. 144 ± 21 mmHg; p<0.01).
  • Healthy controls had lower baseline velocity, higher CFR, and lower blood pressure than hypertensive groups.

Conclusions:

  • Resistant hypertension is associated with impaired cardiac microvascular function, evidenced by reduced CFR.
  • Impaired CFR in resistant hypertension may contribute to increased adverse cardiovascular outcomes.
  • Further research into microvascular function in resistant hypertension is warranted.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
459
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.3K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
359
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
12.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.4K